Skip to content
2000
Volume 1, Issue 3
  • ISSN: 1874-4672
  • E-ISSN: 1874-4702

Abstract

Polyphenolic compounds are widely distributed in the plant kingdom and the anticancer benefits obtained from their consumption have been studied extensively. However, polyphenols are subject to various biotransformation reactions within the human body including methylation. Likewise, naturally occurring polyphenols may contain O-methylations in place of the hydroxyls of the parent compounds. While some studies suggest that methylations can increase the bioavailability of polyphenols, other studies indicate a decrease in the anticancer benefits of methylated polyphenols. This review will focus on the cellular activities of polyphenols, their potential molecular targets and their biological effects after enzymatic methylation. Furthermore, an assessment of the positive and negative aspects of polyphenol methylation on the anticancer activity will be discussed. Finally, the future of polyphenols in both cancer prevention and cancer intervention will be addressed.

Loading

Article metrics loading...

/content/journals/cmp/10.2174/1874467210801030233
2008-11-01
2025-05-17
Loading full text...

Full text loading...

/content/journals/cmp/10.2174/1874467210801030233
Loading

  • Article Type:
    Research Article
Keyword(s): anticancer; drug discovery; molecular target; natural product; Proteasome inhibitor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test